HRP20020214A2 - Quinolyl propyl piperidine derivatives and their use as antibacterial agents - Google Patents

Quinolyl propyl piperidine derivatives and their use as antibacterial agents Download PDF

Info

Publication number
HRP20020214A2
HRP20020214A2 HR20020214A HRP20020214A HRP20020214A2 HR P20020214 A2 HRP20020214 A2 HR P20020214A2 HR 20020214 A HR20020214 A HR 20020214A HR P20020214 A HRP20020214 A HR P20020214A HR P20020214 A2 HRP20020214 A2 HR P20020214A2
Authority
HR
Croatia
Prior art keywords
propyl
methoxyquinolin
piperidine
acid
hydroxy
Prior art date
Application number
HR20020214A
Other languages
English (en)
Croatian (hr)
Inventor
Malleron Jean-Luc
Tabart Michel
Carry Jean-Christophe
Evers Michel
El Ahmad Youssef
Mignani Serge
Viviani Fabrice
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HRP20020214A2 publication Critical patent/HRP20020214A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HR20020214A 1999-09-17 2000-09-14 Quinolyl propyl piperidine derivatives and their use as antibacterial agents HRP20020214A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911679A FR2798656B1 (fr) 1999-09-17 1999-09-17 Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
PCT/FR2000/002541 WO2001025227A2 (fr) 1999-09-17 2000-09-14 Derives de la quinolyl propyl piperidine et leur utilisation en tant que antibacteriens

Publications (1)

Publication Number Publication Date
HRP20020214A2 true HRP20020214A2 (en) 2005-04-30

Family

ID=9549990

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020214A HRP20020214A2 (en) 1999-09-17 2000-09-14 Quinolyl propyl piperidine derivatives and their use as antibacterial agents

Country Status (30)

Country Link
EP (2) EP1218370B1 (cs)
JP (1) JP2004527448A (cs)
KR (1) KR20020038757A (cs)
CN (1) CN1374959A (cs)
AP (1) AP2002002459A0 (cs)
AT (1) ATE284399T1 (cs)
AU (1) AU7429500A (cs)
BG (1) BG106524A (cs)
BR (1) BR0014060A (cs)
CA (1) CA2383836A1 (cs)
CZ (1) CZ2002940A3 (cs)
DE (2) DE60016611T2 (cs)
DZ (1) DZ3195A1 (cs)
EA (1) EA005183B1 (cs)
EE (1) EE200200138A (cs)
FR (1) FR2798656B1 (cs)
GE (1) GEP20043223B (cs)
HR (1) HRP20020214A2 (cs)
HU (1) HUP0204283A3 (cs)
IL (1) IL148720A0 (cs)
MA (1) MA26820A1 (cs)
MX (1) MXPA02001979A (cs)
NO (1) NO20021253L (cs)
OA (1) OA12022A (cs)
PL (1) PL354809A1 (cs)
SK (1) SK3632002A3 (cs)
TN (1) TNSN00184A1 (cs)
WO (1) WO2001025227A2 (cs)
YU (1) YU19002A (cs)
ZA (1) ZA200202073B (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
EP1305308B1 (en) 2000-07-26 2006-12-20 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
EP1470131A2 (en) 2002-01-29 2004-10-27 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
FR2842807A1 (fr) * 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
FR2844270B1 (fr) * 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
EP1551829B1 (de) * 2002-10-10 2010-04-07 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
US7232832B2 (en) 2002-11-05 2007-06-19 Smithkline Beecham Corporation Antibacterial agents
EP1560488B1 (en) 2002-11-05 2010-09-01 Glaxo Group Limited Antibacterial agents
WO2004050036A2 (en) 2002-12-04 2004-06-17 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
DE602005021133D1 (de) * 2004-10-05 2010-06-17 Actelion Pharmaceuticals Ltd Neue piperidin-antibiotika
EP1799674B1 (en) * 2004-10-05 2010-05-05 Actelion Pharmaceuticals Ltd. New piperidine antibiotics
JP2008528598A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
JP2008528586A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
WO2006081182A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
EP1845995A4 (en) 2005-01-25 2010-03-03 Glaxo Group Ltd ANTIBACTERIAL AGENTS
ATE536351T1 (de) 2006-01-26 2011-12-15 Actelion Pharmaceuticals Ltd Tetrahydropyran-antibiotika
EP2001887B1 (en) 2006-04-06 2010-09-15 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
CN101679357A (zh) * 2007-05-09 2010-03-24 辉瑞大药厂 取代的杂环衍生物及其组合物和作为抗菌剂的药物用途
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
EP2352734A1 (en) 2008-10-17 2011-08-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
ES2670550T3 (es) * 2013-10-14 2018-05-30 Eisai R&D Management Co., Ltd. Derivados de quinolina selectivamente sustituidos
US10702521B2 (en) 2014-08-22 2020-07-07 Glaxosmithkline Intellectual Property Development Limited Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
PT3889145T (pt) 2015-12-17 2024-04-02 Merck Patent Gmbh 8-ciano-5-piperidino-quinolinas como antagonistas de tlr7/8 e suas utilizações para tratamento de distúrbios imunitários
EP4198031A1 (en) 2016-08-08 2023-06-21 Merck Patent GmbH Tlr7/8 antagonists and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2318842A1 (en) * 1998-01-26 1999-07-29 Julie Dorothy Warrack Quinoline derivatives as antibacterials
JP2002535323A (ja) * 1999-01-20 2002-10-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー プロテインキナーゼ阻害剤としてのピペリジニルキノリン

Also Published As

Publication number Publication date
EA005183B1 (ru) 2004-12-30
AU7429500A (en) 2001-05-10
DE60016611T2 (de) 2005-12-22
EE200200138A (et) 2003-06-16
FR2798656B1 (fr) 2004-12-17
NO20021253D0 (no) 2002-03-13
YU19002A (sh) 2005-06-10
WO2001025227A2 (fr) 2001-04-12
EA200200374A1 (ru) 2002-10-31
JP2004527448A (ja) 2004-09-09
IL148720A0 (en) 2002-09-12
MXPA02001979A (es) 2002-08-20
AP2002002459A0 (en) 2002-06-30
BG106524A (en) 2003-01-31
DE60034713D1 (de) 2007-06-14
ZA200202073B (en) 2003-08-27
MA26820A1 (fr) 2004-12-20
EP1218370A2 (fr) 2002-07-03
HUP0204283A2 (hu) 2003-04-28
EP1218370B1 (fr) 2004-12-08
EP1484328A1 (fr) 2004-12-08
PL354809A1 (en) 2004-02-23
GEP20043223B (en) 2004-04-26
CA2383836A1 (fr) 2001-04-12
CN1374959A (zh) 2002-10-16
FR2798656A1 (fr) 2001-03-23
HUP0204283A3 (en) 2004-07-28
CZ2002940A3 (cs) 2002-07-17
DZ3195A1 (fr) 2001-04-12
ATE284399T1 (de) 2004-12-15
TNSN00184A1 (fr) 2005-11-10
DE60016611D1 (de) 2005-01-13
WO2001025227A3 (fr) 2001-11-22
EP1484328B1 (fr) 2007-05-02
BR0014060A (pt) 2002-05-21
SK3632002A3 (en) 2003-04-01
DE60034713T2 (de) 2008-01-17
OA12022A (fr) 2006-04-19
KR20020038757A (ko) 2002-05-23
NO20021253L (no) 2002-04-24

Similar Documents

Publication Publication Date Title
HRP20020214A2 (en) Quinolyl propyl piperidine derivatives and their use as antibacterial agents
US6403610B1 (en) Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
US7872031B2 (en) c-MET protein kinase inhibitors
KR100849608B1 (ko) 헤테로사이클릴알킬 피페리딘 유도체, 이의 제조방법 및당해 유도체를 함유하는 조성물
AU2012312303B2 (en) Cyanomethylpyrazole carboxamides as janus kinase inhibitors
US6602884B2 (en) Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
AU2002253219B8 (en) Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
CN114072397A (zh) 杂芳基氨基嘧啶酰胺自噬抑制剂及其使用方法
US20020111492A1 (en) Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
WO2000059502A1 (en) Pyrrolidine modulators of chemokine receptor activity
CZ2002323A3 (cs) Substituované oxoazaheterocyklylové sloučeniny a farmaceutické prostředky, které je obsahují
CZ20032325A3 (cs) Acylované piperidinové deriváty
TW200829243A (en) Azaadamantane derivatives and methods of use
MX2007012463A (es) Heteroarilamidas[3.1.0]biciclicas como inhibidores del transporte de glicina de tipo i.
AU4199700A (en) Pyrrolidine modulators of chemokine receptor activity
WO2006068594A1 (en) HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY
CA2785191A1 (en) Crth2 modulators
JP4688381B2 (ja) ケモカインレセプター活性のｎ−シクロペンチルモジュレーター
US12565494B2 (en) Inhibitors of human respiratory syncytial virus and metapneumovirus
WO2025097090A1 (en) Substituted (piperidin-4-yl)-1,5-naphthyridine and (piperidin-4-yl)quinoline derivatives and uses thereof
HK1151519A (en) C-met protein kinase inhibitors
HK1205508B (en) New bicyclicpyridine derivatives
HK1129890B (en) C-met protein kinase inhibitors for the treatment of proliferative disorders

Legal Events

Date Code Title Description
A1OB Publication of a patent application
OBST Application withdrawn